002551 Stock Overview
Provides hospital construction and medical system integrated solutions in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Shenzhen Glory Medical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.33 |
| 52 Week High | CN¥4.43 |
| 52 Week Low | CN¥2.11 |
| Beta | -0.039 |
| 11 Month Change | 6.73% |
| 3 Month Change | 38.17% |
| 1 Year Change | -24.15% |
| 33 Year Change | -39.34% |
| 5 Year Change | -22.20% |
| Change since IPO | -77.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002551 | CN Construction | CN Market | |
|---|---|---|---|
| 7D | 1.5% | -4.9% | -0.6% |
| 1Y | -24.1% | 5.4% | 3.2% |
Return vs Industry: 002551 underperformed the CN Construction industry which returned 5.4% over the past year.
Return vs Market: 002551 underperformed the CN Market which returned 3.2% over the past year.
Price Volatility
| 002551 volatility | |
|---|---|
| 002551 Average Weekly Movement | 7.6% |
| Construction Industry Average Movement | 7.8% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 002551 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002551's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 1,345 | Guiqiu Liang | www.glory-medical.com.cn |
Shenzhen Glory Medical Co.,Ltd. provides hospital construction and medical system integrated solutions in China and internationally. It operates through Medical Products, Medical Services, and Health Industry segments.
Shenzhen Glory Medical Co.,Ltd. Fundamentals Summary
| 002551 fundamental statistics | |
|---|---|
| Market cap | CN¥2.81b |
| Earnings (TTM) | -CN¥147.68m |
| Revenue (TTM) | CN¥1.28b |
2.2x
P/S Ratio-19.0x
P/E RatioIs 002551 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002551 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.28b |
| Cost of Revenue | CN¥1.14b |
| Gross Profit | CN¥140.26m |
| Other Expenses | CN¥287.94m |
| Earnings | -CN¥147.68m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.18 |
| Gross Margin | 10.99% |
| Net Profit Margin | -11.57% |
| Debt/Equity Ratio | 10.2% |
How did 002551 perform over the long term?
See historical performance and comparison